Strong trader consensus against a new coronavirus pandemic in 2026 stems from persistently low global SARS-CoV-2 circulation, with sentinel surveillance showing test positivity rates at or near all-time lows below 2% in mid-2026 and only modest localized increases since. Official WHO and CDC data indicate declining cases, hospitalizations, and deaths compared with prior years, alongside stable variants under monitoring that lack evidence of enhanced transmissibility or immune escape. This endemic-phase stability, supported by widespread immunity and surveillance integration with routine respiratory monitoring, underpins the 96.2% market-implied odds for no new pandemic. Realistic shifts could arise from emergence of a novel high-risk variant or unrelated coronavirus strain capable of rapid global spread before updated forecasts or genomic data alter assessments.